|
|
|
|
| LEADER |
01839nam a22003375i 4500 |
| 001 |
000276762 |
| 005 |
20210204142223.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2010 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781607614517
|
| 024 |
7 |
|
|a 10.1007/978-1-60761-451-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Cancer and IgE :
|b Introducing the Concept of AllergoOncology /
|c edited by Manuel L. Penichet, Erika Jensen-Jarolim.
|
| 250 |
|
|
|a 1st ed. 2010.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2010.
|
| 300 |
|
|
|a IX, 287 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a The Biology of IgE: Molecular Mechanism Restraining Potentially Dangerous High Serum IgE Titres In Vivo -- The Biology of IgE: The Generation of High-Affinity IgE Antibodies -- Epidemiological Evidence: IgE, Atopy, and Solid Tumors -- Epidemiological Evidence: IgE, Allergies, and Hematopoietic Malignancies -- Mast Cells in Allergy and Tumor Disease -- The IgE Antibody and Its Use in Cancer Immunotherapy -- IgE Interacts with Potent Effector Cells Against Tumors: ADCC and ADCP -- IgE as Adjuvant in Tumor Vaccination -- The Targets of IgE: Allergen-Associated and Tumor-Associated Molecular Patterns -- The Role of Th2-Mediated Anti-Tumor Immunity in Tumor Surveillance and Clearance.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
1 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Penichet, Manuel L.
|e editor.
|
| 700 |
1 |
|
|a Jensen-Jarolim, Erika.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|